Read + Share
Amedeo Smart
Independent Medical Education
Smith PJ, Critchley L, Storey D, Gregg B, et al. Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. J Crohns Colitis 2022;16:1436-1446.PMID: 35390141
Email
LinkedIn
Facebook
Twitter
Privacy Policy